OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · Real-Time Price · USD
1.115
+0.015 (1.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
OKYO Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 |
| Market Capitalization | 38 | 50 | 34 | 109 | 74 | 6 | |
| Market Cap Growth | 18.06% | 47.06% | -68.99% | 46.71% | 1100.45% | 7.04% | |
| Enterprise Value | 37 | 48 | 33 | 103 | 67 | 6 | |
| Last Close Price | 1.11 | 1.49 | 1.32 | 5.14 | 7.15 | 0.71 | |
| PB Ratio | -5.24 | -8.42 | -16.40 | 36.84 | 13.94 | -54.55 | |
| P/TBV Ratio | - | - | - | 36.84 | 13.94 | - | |
| Debt / Equity Ratio | 0.00 | - | -1.08 | - | 0.02 | -0.23 | |
| Quick Ratio | 0.25 | 0.19 | 0.69 | 2.65 | 4.08 | 0.76 | |
| Current Ratio | 0.28 | 0.21 | 0.72 | 3.17 | 4.09 | 0.80 | |
| Return on Equity (ROE) | - | - | -2968.51% | -131.55% | -130.13% | -1705.57% | |
| Return on Assets (ROA) | - | -291.87% | -173.43% | -68.30% | -54.34% | -141.59% | |
| Return on Capital (ROIC) | - | - | -530.16% | -93.01% | -79.58% | -898.25% | |
| Earnings Yield | -28.25% | -33.98% | -39.41% | -5.00% | -4.53% | -19.70% | |
| FCF Yield | -7.77% | -19.16% | -22.87% | -5.04% | -2.17% | -15.59% | |
| Buyback Yield / Dilution | -42.96% | -31.84% | -47.74% | -45.55% | -12.98% | -15.87% | |
| Total Shareholder Return | -42.96% | -31.84% | -47.74% | -45.55% | -12.98% | -15.87% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.